📋 Tender Overview
Elsevier a global research publishing and information analytics provider and part of RELX has acquired SciBite a semantic AI company headquartered in Cambridge UK to help customers make faster more effective RD decisions through advanced text and data intelligence solutions.SciBites solutions identify and extract scientific insights from structured and unstructured text and content to identify key concepts such as drugs proteins companies targets and outcomes. This semantically-enriched machine-readable data helps SciBites customers around the world make streamlined more efficient decisions.SciBite was founded in 2011 by Dr. Lee Harland who currently serves as Chief Scientific Officer at the company with a mission to help customers better understand the complexities of life sciences data. SciBites major products include TERMite an AI and ontology driven text analysis engine DOCstore which transforms search through semantic indexing and CENtree a next-generation collaborative ontology management platform they are complemented by a suite of apps that support its core technology and allow customers to automate data-curation and manage terminology standards.Dr. Harland said I am incredibly proud of everyone at SciBite we believe that our continued investment in innovative technology enables our customers to address the huge challenges they face in creating connecting and analyzing disparate content and data. Our track record in driving new insights and efficiencies within drug discovery and the wider life sciences is something we will continue to build upon in this next phase of our journey.Rob Greenwood CEO and President SciBite said This is an exciting next step for our business. The combined offering of Elseviers high-quality content and data and the innovative technology from SciBite will deliver amazing value for any data led strategy across the scientific community. As part of the Elsevier organization SciBite will have the ability to deliver enterprise technology and new advances in scientific insight and discovery across its broad reaching global customer base.Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. To support this Elseviers Life Sciences Solutions division is transforming from a provider of reference solutions into a creator of data and information analytics capable of supporting multiple scientific domain-specific use cases ranging from search and discovery through to machine learning and AI.SciBites proven and award-winning solutions will enable Elsevier to develop its Life Sciences Solutions services such as Reaxys which powers chemistry research and development Embase the worlds most comprehensive international database of biomedical information and Entellect its FAIR data compliant platform that integrates stores and enriches client data with Elsevier and third-party content into a common analytical environment.Cameron Ross Managing Director Life Sciences Solutions Elsevier said The life sciences and corporate RD communities face complex challenges with an ever-expanding sea of data and content to extract knowledge from. We aim to combine Elseviers expertise and content from existing products with SciBites impressive capabilities and suite of ontology-led products to support more customers around the world make data led decisions in the drug development process.Stuart Whayman Chief Commercial Officer Elsevier said Elsevier and SciBite have an aligned vision to better understand the complexities of the life sciences to better serve our customers a vision which we believe will create exciting opportunities in the future. I am very pleased to welcome the SciBite team to Elsevier and look forward to working with them in the future.
